Topic: regenerative medicine
The framework builds on the 21st Century Cures Act by setting criteria for the RMAT designation and outlining the benefits of the regulatory status.
An Amgen-backed $25 million series B sets startup Fortuna to move candidates against Parkinson’s disease and spinal cord injury into the clinic.
Scientists have discovered key stem cells that help the gecko tail regenerate—insights that may spur therapies for people with spinal cord injuries.
The past week saw news of a partnership aimed at improving cancer discovery, a technique for reversing heart damage and a new cancer-killing cell.
Scientists from the Wellcome Trust Sanger Institute have created a new type of stem cell that retains the ability to develop into any type of cell.
Avita Medical aims to raise $13.2 million to support its regenerative burn treatment through FDA submission and U.S. launch.
Scientists at Baylor have discovered that when they silence a signaling pathway in the body called Hippo, they can reverse heart failure in mice.
PolarityTE announced the FDA registration of its skin-regeneration platform, which it will introduce in a limited release.
MiMedx is divesting Stability Biologics, its bone graft subsidiary, back to its shareholders as it “transitions” into a biopharmaceutical company.
A University of Toronto team reported promising results from a trial of tiny injectable patches made from cardiac tissue.